Home › Funds › Frazier Life Sciences Management, L.P. › EOLS

Frazier Life Sciences Management, L.P. position in EOLS

EVOLUS INC · Health Care

Frazier Life Sciences Management, L.P. reported holding 2,630,665 shares of EOLS (EVOLUS INC) in its Q2 2026 13F filing — a position valued at US$18.3M, representing 0.40% of its reported portfolio and ranking #35 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed EOLS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)2.63M sh
Reported value held$18.26M
Portfolio Weight0.40%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s EOLS position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in EOLS in Q2 2025 at 2,435,550 shares (US$22.4M). Across 5 filings, Frazier Life Sciences Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 2,630,665 shares valued at US$18.3M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 2.44M $22.43M New
Q3 2025 2.63M $16.15M Add
Q4 2025 2.63M $17.49M Hold
Q1 2026 2.63M $10.81M Hold
Q2 2026 2.63M $18.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EOLS and 13F data

EOLS (EVOLUS INC) is a Health Care company. 21 other funds we track also report a position in EOLS — the largest reported positions include Nantahala Capital Management, LLC (US$38.9M), BRAIDWELL LP (US$21.9M), Soviero Asset Management, LP (US$5.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EOLS

All EOLS fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held EOLS?

Frazier Life Sciences Management, L.P. has disclosed EOLS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Frazier Life Sciences Management, L.P.'s current position in EOLS?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 2.63M shares of EOLS (EVOLUS INC), valued at $18.26M, representing 0.40% of its reported portfolio and ranking #35.

Has Frazier Life Sciences Management, L.P. been buying or selling EOLS?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in EOLS.

Which other funds hold EOLS?

Other major institutional holders of EOLS include Nantahala Capital Management, LLC, BRAIDWELL LP, Soviero Asset Management, LP, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.